CME
CME Group Inc
267.20$
-3.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 58.9% | 56.3% | 57.7% | 61.9% | 54.1% | 52.6% | 71.6% | 82.2% | 79.8% | 73.2% | 75.0% | 2.6% | |
| 1.9% | 2.5% | 2.7% | 2.5% | 1.8% | 2.1% | 1.3% | 1.4% | 1.6% | 2.2% | 2.1% | 2.2% | |
| 2.0% | 2.6% | 2.8% | 2.6% | 1.9% | 2.2% | 1.4% | 1.5% | 1.6% | 2.3% | 2.2% | 2.3% | |
| 0.5% | 0.5% | 0.5% | 0.5% | 0.7% | 0.7% | 0.4% | 0.2% | 0.3% | 0.4% | 0.4% | 0.3% | |
| 56.2% | 52.8% | 54.2% | 58.3% | 50.9% | 49.3% | 69.6% | 80.3% | 77.7% | 73.2% | – | – | |
| 0.7% | 0.7% | 0.6% | 0.5% | 0.6% | 0.7% | 0.5% | 0.3% | 0.5% | – | – | – | |
| 10.5% | 11.2% | 10.9% | 10.0% | 13.9% | 14.3% | 8.7% | 5.4% | 6.0% | 8.1% | 7.6% | 5.3% | |
| 27.4% | 29.3% | 28.3% | 25.8% | 29.3% | 29.6% | 17.7% | 10.5% | 11.7% | 15.6% | 14.5% | 10.0% | |
| 71.0% | 69.5% | 70.7% | 70.4% | 66.5% | 65.2% | 78.9% | 86.1% | 84.6% | 79.4% | 80.7% | 85.5% | |
| 57.5% | 54.7% | 56.1% | 60.3% | 53.3% | 51.2% | 70.8% | 81.5% | 79.1% | 72.0% | 74.4% | 80.7% | |
| – | – | – | – | 0.7% | 0.1% | 0.0% | 0.4% | 0.0% | 0.0% | 0.5% | 0.0% | |
| 0.1% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | 0.1% | 0.1% | 0.0% | |
| 2.9% | 3.3% | 3.2% | 2.9% | 4.9% | 5.0% | 2.8% | 1.4% | 2.0% | 2.6% | 1.9% | 1.7% | |
| 29.0% | 30.5% | 29.3% | 29.6% | 33.5% | 34.8% | 21.1% | 13.9% | 15.4% | 20.6% | 19.3% | 14.5% | |
| 4.6% | 4.3% | 3.6% | 5.9% | 6.3% | 6.7% | 4.0% | 2.6% | 2.7% | 3.4% | 3.0% | 3.2% | |
| 0.5% | 0.5% | 0.5% | 0.4% | 0.4% | 0.5% | 0.3% | 0.2% | 0.2% | 0.3% | 0.3% | 0.2% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.